top of page
.png)
All Posts
Trip Your Way to Better Health? Researchers See MedicalPotential in Ketamine, Mushrooms and Ibogaine
Decades after psychedelics were classified as Schedule I drugs with “no medical value,” science is forcing a reevaluation. From ketamine’s medical use to psilocybin and ibogaine advancing through clinical trials, researchers and clinicians are challenging stigma with data—driven by the urgent need to address PTSD, treatment-resistant depression, addiction, and the ongoing opioid crisis.
-
Jan 29 min read
Don’t Expect Gummies or Chocolates at Colorado Psilocybin Centers
Colorado’s regulated psilocybin model is taking a different path than Oregon’s by prioritizing integration with existing healthcare. By allowing therapists to license their offices as micro-healing centers, Colorado enables talk therapy, psychiatry, and psilocybin services to coexist under one roof—creating a more accessible, trusted framework for psychedelic-assisted care.
-
Dec 22, 20255 min read
Tricycle Day: Psychonaut POV Q&A with Rhonda DeSantis, Founder & Cultivator
Psychonaut POV Q&A with Rhonda DeSantis , Founder & Cultivator Henry Winslow-- December 14, 2025 You already run a successful construction company. Why get involved in the emerging psilocybin industry in Colorado at all? For me it was a life-changing experience. I had a very small dose of psilocybin that helped me through a critical time in my life, and from that one experience I had a dramatic reduction in trauma triggers. I did three more of those same small doses over the
-
Dec 14, 20255 min read
Yahoo! Finance: Psylutions Leads Colorado's Regulated Psychedelic Market with Healing Center Collaborations
Colorado Builds America’s First Psychedelic Care System
-
Dec 12, 20251 min read
GreenState: Meet the Trauma Survivor Quietly Shaping Colorado’s Psychedelic Future
Psylutions Founder on Precision, Safety & Healing-Focused Psychedelic Care
-
Dec 4, 20251 min read
High Times: Colorado’s First Psychedelic Care System
Colorado Builds America’s First Psychedelic Care System
-
Nov 22, 20251 min read
Honeysuckle Magazine: DEA Rescheduling Milestone
A New Chapter for Regulated Psilocybin Therapies
-
Nov 1, 20251 min read
Microdose: Psylutions and the DEA
After more than fifty years classified as having “no medical value,” psilocybin may finally be evaluated through the lens of science rather than stigma. The DEA’s decision to advance rescheduling review marks a turning point for patients facing terminal illness, veterans struggling with PTSD, and researchers working to expand treatment options. As access and accountability converge, a new chapter in psychedelic medicine is beginning.
-
Sep 23, 20253 min read
City Buzz: Psylutions Founder Stresses Importance of Regulated Producers
City Buzz: Psylutions Founder stresses importance of regulated producers in the wake of findings of mislabeling in psychedelic edibles
-
Sep 15, 20252 min read
Denver Post: Psychedelic Science Conference & Psylutions
Pioneering Psilocybin in Practice at Psychedelic Science 2025
-
Aug 1, 20251 min read
-
Jan 1, 20253 min read
Psylutions Strain Guide: PE, TW, APE, TAT, BV, BG and GT – What’s the Difference?
Psylutions Strain Guide: PE, TW, APE, TAT, BV, BG and GT – What’s the Difference?
-
Dec 5, 20245 min read
What If I Want a Mix of Doses and Strains?
What If I Want a Mix of Doses and Strains?
-
Oct 1, 20243 min read
The Milligram Guide: How to Dose Psilocybin and Choose the Right Strain
How to Choose the Right Low-Dose Psilocybin Experience
-
Oct 1, 20241 min read
-
Jul 24, 20241 min read
-
Jul 24, 20241 min read
bottom of page